Quest Diagnostics Reports Second Quarter 2019 Financial Results

Go back to Quest Diagnostics Reports Second Quarter 2019 Financial Results

Quest Diagnostics (DGX) Tops Q2 EPS by 5c, Revenues Beat; Offers FY19 EPS/Revenue Guidance

July 23, 2019 6:47 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.73, $0.05 better than the analyst estimate of $1.68. Revenue for the quarter came in at $1.95 billion versus the consensus estimate of $1.94 billion.

"Our volume growth accelerated in the second quarter due to our expanded network access,... More